This information was published on 2026-08-21T00:08:35 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2644072 |
| (220) |
13 Apr 2026
|
| (300) |
US, 20 Mar 2026, 99715547
|
| (511) (510) |
Class 5
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease |
| (540) | DUHUNTX |
| (550) | Word |
| (730) |
Skyhawk Therapeutics, Inc.
|
| (750) |
Clayton Utz
|
Find out more about publications on the About page.